JEHOSHAPHAT REICH: Open Payments
NPI 1821658964 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,216 in 65 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $445 · 2025 $1,216
Food & beverage: $1,216
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 16 | $240 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $175 |
| Neurocrine BioSciences, Inc. | 8 | $160 |
| Teva Pharmaceuticals USA, Inc. | 7 | $152 |
| Lundbeck LLC | 8 | $145 |
| Axsome Therapeutics, Inc. | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Sage Therapeutics, LLC | 2 | $53 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
Products named: ARISTADA, REXULTI, CAPLYTA, INGREZZA, UZEDY, Auvelity, AUSTEDO XR, ZURZUVAE.
Industry payments across PA — which companies pay providers there.
